OMX Nordic 40
|
2 351,54
|
-7,18
|
-0,30 %
|
Analysen zu OMX Nordic 40-Werten
| 30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.01.24 | Volvo AB Buy | Deutsche Bank AG | |
| 30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 29.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
| 29.01.24 | Nokia Hold | Jefferies & Company Inc. | |
| 26.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
| 26.01.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 26.01.24 | Volvo AB Sell | UBS AG | |
| 25.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Nokia Underweight | Barclays Capital | |
| 25.01.24 | Nokia Neutral | UBS AG | |
| 25.01.24 | Nokia Hold | Jefferies & Company Inc. | |
| 25.01.24 | Volvo AB Sell | UBS AG | |
| 25.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 24.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 23.01.24 | Ericsson Neutral | UBS AG | |
| 23.01.24 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 23.01.24 | Ericsson Buy | Jefferies & Company Inc. | |
| 22.01.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
| 19.01.24 | ABB Sector Perform | RBC Capital Markets | |
| 19.01.24 | Nokia Underweight | Barclays Capital | |
| 18.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 17.01.24 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 16.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.01.24 | AstraZeneca Sell | UBS AG | |
| 15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | Volvo AB Buy | Deutsche Bank AG | |
| 15.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 15.01.24 | ABB Sector Perform | RBC Capital Markets | |
| 09.01.24 | ABB Hold | Jefferies & Company Inc. | |
| 08.01.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | ABB Market-Perform | Bernstein Research | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.01.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | Nokia Neutral | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.